As pressure increasingly builds on public and charitable sources of research funding, there is growing concern that money from the pharmaceutical industry may come with pitfalls for unwary researchers, Britain's science academy, the Royal Society, concluded last month.
Royal Society members, who held their annual alumni meeting, fear that the government's drive to increase university-industry collaboration on research could lead to scientific results becoming biased. Patrick Bateson, the society's vice-president, said that commercial opportunities were already affecting the choice of research topics. He said that scientists were leaning towards projects with short-term financial benefits instead of concentrating on long-term public need.
He said: "We want to counter the trend towards more and more funding from industry. We want to push in the other direction from government." He said that many scientists were not aware of the potential pitfalls of corporate funding and that the effects of commercial influence on research could be subtle.
Bateson Sources suggest that the DFG has managed to carve out a special solution for itself, with a possible budget rise of up to 2.5%. At the Max-Planck society, however, the preliminary budget is set on the assumption that the budget freeze will be implemented. The inevitable response of the society will be to proceed with a consolidation programme which was outlined by MPG president professor Peter Gruss last December in response to the first announcement of a freeze.
Pointing to the fact that the budget conditions had already been tight for many years, Gruss announced the closure of 20 departments (Abteilungen), representing just under 10% of the society's research facilities. Most of the closures will take advantage of the retirement of existing directors. The general policy of the society has always been that departments, each of which is dedicated to one topical research field, may be shut down on retirement of the director, to make place for a new department focussed on a new field. So the main difference now is thatover the next seven years or so -20 departments will be closed without replacement, which will reduce the size of institutes and possibly lead to the closing down of a few smaller ones. It is expected that the Senate, the steering committee of the society, will approve the consolidation plan and this year's budget at its meeting on June 5th. After this meeting, the president will decide on the closures after consultation with the institutes concerned. So far, no specific closures can be officially confirmed.
While there had been fears that the need for consolidation might put the 'reconstruction plan' for the former East Germany at risk, the society's press secretary, Dr Bernd Wirsing, insists that "this plan will go ahead, although some of the new institutes may end up having fewer departments than we originally planned." Overall, most of the programme for East Germany has already been implemented, and the 20 institutes that sprang from it are up and running, teeming with 4,000 employees. Thus, the East/West division is no longer a central issue and the new consolidation program will not include any geographical discrimination in either direction.
Even after a 10% cutback, the Max-Planck society will undisputedly remain the major player for fundamental research in Germany. The challenge for the society is, however, to remain competitive internationally. It is Germany's most efficient dam against the brain drain, and any cost-cutting that undermines this function might in the end cost more than it saves.
